NextGen Healthcare Competitors

Scientific Games (NASDAQ:SGMS) and NextGen Healthcare (NASDAQ:NXGN) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Scientific Games and NextGen Healthcare, as provided by MarketBeat.com.

Scientific Games currently has a consensus target price of $39.2857, suggesting a potential downside of 16.11%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given NextGen Healthcare's higher possible upside, analysts clearly believe NextGen Healthcare is more favorable than Scientific Games.

Profitability

This table compares Scientific Games and NextGen Healthcare's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Scientific Games and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

NextGen Healthcare has lower revenue, but higher earnings than Scientific Games. NextGen Healthcare is trading at a lower price-to-earnings ratio than Scientific Games, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

89.5% of Scientific Games shares are held by institutional investors. Comparatively, 71.3% of NextGen Healthcare shares are held by institutional investors. 40.6% of Scientific Games shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Scientific Games has a beta of 2.11, meaning that its share price is 111% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

NextGen Healthcare beats Scientific Games on 9 of the 14 factors compared between the two stocks.

Parsons (NYSE:PSN) and NextGen Healthcare (NASDAQ:NXGN) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Parsons and NextGen Healthcare, as provided by MarketBeat.com.

Parsons currently has a consensus target price of $38.50, suggesting a potential upside of 7.72%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given Parsons' higher possible upside, research analysts clearly believe Parsons is more favorable than NextGen Healthcare.

Profitability

This table compares Parsons and NextGen Healthcare's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Parsons and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Parsons has higher revenue and earnings than NextGen Healthcare. Parsons is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

71.3% of NextGen Healthcare shares are held by institutional investors. 0.2% of Parsons shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Parsons has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

NextGen Healthcare beats Parsons on 8 of the 13 factors compared between the two stocks.

Verint Systems (NASDAQ:VRNT) and NextGen Healthcare (NASDAQ:NXGN) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Verint Systems and NextGen Healthcare, as provided by MarketBeat.com.

Verint Systems currently has a consensus target price of $65.8571, suggesting a potential upside of 33.61%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given Verint Systems' stronger consensus rating and higher possible upside, research analysts clearly believe Verint Systems is more favorable than NextGen Healthcare.

Profitability

This table compares Verint Systems and NextGen Healthcare's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Verint Systems and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Verint Systems has higher revenue and earnings than NextGen Healthcare. Verint Systems is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

95.9% of Verint Systems shares are held by institutional investors. Comparatively, 71.3% of NextGen Healthcare shares are held by institutional investors. 1.4% of Verint Systems shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Verint Systems has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

Verint Systems beats NextGen Healthcare on 10 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and NextGen Healthcare (NASDAQ:NXGN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Institutional and Insider Ownership

71.3% of NextGen Healthcare shares are held by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Allscripts Healthcare Solutions and NextGen Healthcare, as provided by MarketBeat.com.

Allscripts Healthcare Solutions currently has a consensus target price of $10.8667, suggesting a potential downside of 29.57%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given NextGen Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe NextGen Healthcare is more favorable than Allscripts Healthcare Solutions.

Volatility & Risk

Allscripts Healthcare Solutions has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Earnings & Valuation

This table compares Allscripts Healthcare Solutions and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

NextGen Healthcare has lower revenue, but higher earnings than Allscripts Healthcare Solutions. NextGen Healthcare is trading at a lower price-to-earnings ratio than Allscripts Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Allscripts Healthcare Solutions and NextGen Healthcare's net margins, return on equity and return on assets.

Summary

NextGen Healthcare beats Allscripts Healthcare Solutions on 12 of the 13 factors compared between the two stocks.

NextGen Healthcare (NASDAQ:NXGN) and Telos (NASDAQ:TLS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Insider & Institutional Ownership

71.3% of NextGen Healthcare shares are owned by institutional investors. 18.5% of NextGen Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for NextGen Healthcare and Telos, as reported by MarketBeat.

NextGen Healthcare currently has a consensus price target of $16.50, suggesting a potential downside of 11.76%. Telos has a consensus price target of $35.8571, suggesting a potential upside of 7.61%. Given Telos' stronger consensus rating and higher possible upside, analysts plainly believe Telos is more favorable than NextGen Healthcare.

Valuation and Earnings

This table compares NextGen Healthcare and Telos' gross revenue, earnings per share and valuation.

NextGen Healthcare has higher revenue and earnings than Telos.

Profitability

This table compares NextGen Healthcare and Telos' net margins, return on equity and return on assets.

Summary

NextGen Healthcare beats Telos on 6 of the 9 factors compared between the two stocks.

NextGen Healthcare (NASDAQ:NXGN) and NetScout Systems (NASDAQ:NTCT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Insider & Institutional Ownership

71.3% of NextGen Healthcare shares are owned by institutional investors. Comparatively, 94.7% of NetScout Systems shares are owned by institutional investors. 18.5% of NextGen Healthcare shares are owned by company insiders. Comparatively, 4.4% of NetScout Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for NextGen Healthcare and NetScout Systems, as reported by MarketBeat.

NextGen Healthcare currently has a consensus price target of $16.50, suggesting a potential downside of 11.76%. NetScout Systems has a consensus price target of $24.6667, suggesting a potential downside of 12.59%. Given NextGen Healthcare's stronger consensus rating and higher possible upside, equities research analysts plainly believe NextGen Healthcare is more favorable than NetScout Systems.

Risk & Volatility

NextGen Healthcare has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, NetScout Systems has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

Valuation and Earnings

This table compares NextGen Healthcare and NetScout Systems' gross revenue, earnings per share and valuation.

NextGen Healthcare has higher earnings, but lower revenue than NetScout Systems. NetScout Systems is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares NextGen Healthcare and NetScout Systems' net margins, return on equity and return on assets.

Summary

NextGen Healthcare beats NetScout Systems on 9 of the 14 factors compared between the two stocks.